Published in:
Blog
Navigating Technology Transfer in Pharmaceutical and BIIoTech Manufacturing
Author
admin
The pharmaceutical, bIIoTech, and medical device industries are pillars of innovation and progress, and a key enabler of their evolution is the process known as technology transfer. At its core, technology transfer is the systematized exchange of knowledge between entities, often relating to product formulation, production processes, quality control, and regulatory requirements. It is a crucial endeavor to ensure the seamless transition of manufacturing from the lab scale to large-scale commercial production, all while maintaining the same product quality and efficacy established during development and clinical trials.
This critical operation may seem straightforward, but anyone who has been involved in such a process knows that it is anything but. It involves a complex matrix of factors, ranging from technical knowledge to process description documents, from raw material sourcing to change management plans, and from process parameters to quality attributes. The way these factors are managed and executed often determines the success or failure of the entire technology transfer, with implications that can significantly affect the manufacturing process, product quality, time-to-market, and cost efficiency.
In this blog post, we’ll unpack the intricacies of technology transfer, discussing its different classifications based on product development stages and team involvement, highlighting the key elements that influence a successful transfer, and presenting an overview of common challenges faced during the process.
Additionally, we’ll showcase how Tulip can help alleviate common pain points and streamline the technology transfer process, fostering efficiency, standardization, and proactive decision-making.
What is a technology transfer?
A technology transfer is broadly defined as the exchange of product and/or process knowledge between two organizations. The original owner of the information is typically referred to as the sponsor or marketing authorization holder (MAH), whereas the receiver is often called a recipient or transferee. This process can include the transfer of knowledge related to product formulation, production processes, quality control testing, regulatory requirements, and more. The ultimate goal is to reproduce the same product quality and efficacy as demonstrated during development and clinical trials.What’s included in a technology transfer?
There are generally two categories of information included in a tech transfer: Process Description Doc- Inventory: This document lists the raw materials, consumables, equipments, and their amounts used to manufacture the transferred technology.
- SOPs, CPPs, and CQAs: It also tracks the necessary SOPs, parameters, and specifications involved in the manufacturing process to ensure consistency and provide clear guidelines for the recipient.
- Validation and Qualification Data: Validation and qualification data should also be provided in order to ensure the transferred technology meets the required standards and regulatory compliance
- Documentation: A quality management plan will hold all documentation related to quality control and quality assurance processes essential to for tech transfers. This includes information about inspections, quality control checkpoints, and maintenance services.
- Training Materials: It will also have training materials like manuals, presentations, and videos so that a new team of operators is able to recreate the transferred technology.
- Change Management: To ensure traceability, the quality management plan will track changes in the manufacturing process, which can typically involve equipment sizes or raw material suppliers.